P
Peter M. Rothwell
Researcher at University of Oxford
Publications - 815
Citations - 77220
Peter M. Rothwell is an academic researcher from University of Oxford. The author has contributed to research in topics: Stroke & Population. The author has an hindex of 134, co-authored 779 publications receiving 67382 citations. Previous affiliations of Peter M. Rothwell include Leicester Royal Infirmary & University of Edinburgh.
Papers
More filters
Journal ArticleDOI
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: A multicenter study
Matthew F. Giles,Gregory W. Albers,P. Amarenco,Ethem Murat Arsava,A.W. Asimos,Hakan Ay,D. Calvet,Shelagh B. Coutts,B.L. Cucchiara,A.M. Demchuk,S. C. Johnston,P.J. Kelly,Anthony S. Kim,J. Labreuche,P.C. Lavallee,J.-L. Mas,Aine Merwick,Jean-Marc Olivot,Francisco Purroy,W.D. Rosamond,R. Sciolla,Peter M. Rothwell +21 more
TL;DR: The concept of a tissue-based definition of TIA and stroke, at least on prognostic grounds, is supported, especially after a 90-day follow-up.
Journal ArticleDOI
Total small vessel disease score and risk of recurrent stroke Validation in 2 large cohorts
Kui Kai Lau,Linxin Li,Ursula G. Schulz,Michela Simoni,Koon-Ho Chan,Shu-Leong Ho,Raymond T.F. Cheung,Wilhelm Küker,Henry K.F. Mak,Peter M. Rothwell +9 more
TL;DR: The total SVD score has predictive value for recurrent stroke after TIA/ischemic stroke, and prediction of recurrence in patients with nonlacunar events highlights the potential role of SVD in wider stroke etiology.
Journal ArticleDOI
Stroke: Working toward a Prioritized World Agenda
Vladimir Hachinski,Geoffrey A. Donnan,Philip B. Gorelick,Werner Hacke,Steven C. Cramer,Markku Kaste,Marc Fisher,Michael Brainin,Alastair M. Buchan,Eng H. Lo,Brett E. Skolnick,Karen L. Furie,Graeme J. Hankey,Miia Kivipelto,John C. Morris,Peter M. Rothwell,Ralph L. Sacco,Sidney C. Smith,Yulun Wang,Alan Bryer,Gary A. Ford,Costantino Iadecola,Sheila Cristina Ouriques Martins,Jeffrey L. Saver,Skvortsova Vi,Mark Bayley,Martin M. Bednar,Pamela W. Duncan,Lori A. Enney,Seth P. Finklestein,Theresa A. Jones,Lalit Kalra,Jeff Kleim,Ralph Nitkin,Robert Teasell,Cornelius Weiller,Bhupat Desai,Mark P. Goldberg,Wolf-Dieter Heiss,Osmo Saarelma,Lee H. Schwamm,Yukito Shinohara,Bhargava Trivedi,Nils Wahlgren,Lawrence K. Wong,Antoine Hakim,Bo Norrving,Stephen Prudhomme,Natan M. Bornstein,Stephen M. Davis,Larry B. Goldstein,Didier Leys,Jaakko Tuomilehto +52 more
TL;DR: The aim of the Synergium was to devise and prioritize new ways of accelerating progress in reducing the risks, effects, and consequences of stroke by using a ***‘Brain Health’ concept that enables promotion of preventive measures.
Journal ArticleDOI
Quality of life after TIA and stroke: Ten-year results of the Oxford Vascular Study
Ramon Luengo-Fernandez,Alastair Gray,Linda M. Bull,Sarah Welch,Fiona C. Cuthbertson,Peter M. Rothwell +5 more
TL;DR: Quality-adjusted survival is low over the 5 years after stroke and TIA, with severity and recurrent stroke being major predictors, and considerable scope for improvements in acute treatment and secondary prevention to improve the quality of life.
Journal ArticleDOI
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.
Luis A. García Rodríguez,Mar Martín-Pérez,Charles H. Hennekens,Peter M. Rothwell,Angel Lanas +4 more
TL;DR: The risks of major bleeding with low-dose aspirin in real-world settings are of a similar magnitude to those reported in randomized trials and will help inform clinical judgements regarding the use of low- dose aspirin in prevention of cardiovascular events.